Sowell Financial Services LLC Has $3.17 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Sowell Financial Services LLC increased its position in The Clorox Company (NYSE:CLX) by 2.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,551 shares of the company’s stock after purchasing an additional 473 shares during the quarter. Sowell Financial Services LLC’s holdings in Clorox were worth $3,173,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Redwood Park Advisors LLC acquired a new position in Clorox during the 4th quarter valued at about $26,000. Millstone Evans Group LLC bought a new stake in shares of Clorox during the fourth quarter worth approximately $31,000. Wood Tarver Financial Group LLC acquired a new position in Clorox in the fourth quarter valued at approximately $31,000. GKV Capital Management Co. Inc. bought a new position in Clorox in the fourth quarter valued at approximately $32,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in Clorox during the 4th quarter worth $33,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. JPMorgan Chase & Co. cut their price target on Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 6th. Morgan Stanley dropped their price objective on Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. Evercore ISI set a $140.00 target price on Clorox and gave the stock an “underperform” rating in a report on Tuesday, May 6th. UBS Group decreased their target price on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a research report on Thursday, April 17th. Finally, Citigroup cut their price target on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research report on Monday, April 14th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $151.23.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the stock in a transaction dated Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the acquisition, the director now directly owns 4,000 shares of the company’s stock, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.57% of the company’s stock.

Clorox Stock Up 0.6%

Clorox stock opened at $123.82 on Tuesday. The stock has a market capitalization of $15.26 billion, a PE ratio of 33.83, a price-to-earnings-growth ratio of 2.62 and a beta of 0.54. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a twelve month low of $122.84 and a twelve month high of $171.37. The company has a 50 day moving average of $134.66 and a 200-day moving average of $147.91.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business’s revenue for the quarter was down 8.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.71 earnings per share. On average, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.